A Review on The Global Widespread of TTV Infection Among Humans Population by Jarkasi, Nur Syazwani et al.
PJSRR (2018) 4(1): 10-24 
eISSN: 2462-2028 © Universiti Putra Malaysia Press 
 
10 
 
  
 
 
 
Pertanika Journal of Scholarly Research Reviews 
http://www.pjsrr.upm.edu.my/ 
 
 
A Review on The Global Widespread of TTV Infection Among Humans 
Population 
 
Nur Syazwani JARKASIa, Zamberi SEKAWIb, Cheah YOKE KQUEENa, Zulkefley OTHMANa* 
 
aDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences,  
Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia  
bDepartment of Medical Microbiology and Parasitology, Faculty of Medicine and Health Sciences, 
Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.  
*zulkefley_os@upm.edu.my 
 
Abstract – Torque Teno Virus (TTV) is a human-infected virus that is present ubiquitously in nature. 
Globally, it infects up to 95% of the healthy individuals without any clinical manifestations. The 
widely used laboratory diagnosis of TTV infection is Polymerase chain reaction (PCR). Nevertheless, 
several other methods have been developed. The rapid growth of TTV variants over time has posed a 
challenge in estimating the global TTV infection as none of the PCR protocol has the ability to detect 
the entire spectrum of TTV variants. Multiple TTV epidemiological studies have been conducted 
among Asian population, whereas other continents showed a limited number of studies. The 
horizontal and vertical transmission of TTV among humans population, as well as interspecies 
transmission are potentially related to the global widespread of TTV infection.  
 
Keywords: Torque Teno Virus (TTV), Untranslated region (UTR), N22-region, TTV variants, global 
TTV infection, intra- and interspecies transmission 
 
 
Introduction 
A metagenomics analysis has revealed a variety of novel human-blood virome, and interestingly, 70% 
of the total human virome detected was a single-stranded Anellovirus DNA where in particular, 95% 
of the total Anellovirus DNA belongs to TTV (De Vlaminck et al., 2013). A study on TTV has begun 
two decades ago after a group of researchers has successfully isolated this novel DNA virus from a 
serum of a Japanese patient with hepatitis of unexplained aetiology (Nishizawa et al., 1997). This 
small (30 to 50 nm in diameter), non-enveloped virus (Okamoto et al., 1998a; Mushahwar et al., 1999; 
Itoh et al., 2000) has been assigned into the genus Alphatorquevirus, a member of Anelloviridae 
family, and there are other 11 genera that have been assigned into this family (Table 1). TTV and the 
other two closely related genera, Betatorquevirus and Gammatorquevirus, are known as a human-
infected virus, while the other genera are classified as animal-infected virus (ICTV, 2015).  
 
Soon after the discovery of TTV, a number of publications exist investigating the molecular aspect of 
TTV as well as determining the prevalence of TTV DNA in various types of clinical specimens. 
However, this so-called orphan virus has long been ignored probably due to the absence of an 
efficient culture system. Many aspects of this virus are still poorly understood and the growing 
literature on the epidemiological aspect of TTV demonstrated that the prevalence of this virus is 
geographically variable independent of sociodemographic factors of the studied population (Massaú et 
al., 2012; Mazzola et al., 2015).  
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Table 1: The members of Anelloviridae family (Source: ICTV, 2015) 
Genus Species Infected host 
Alphatorquevirus Torque teno virus Human, chimpanzee 
Betatorquevirus Torque teno mini virus Human, non-human primate 
Deltatorquevirus Torque teno tupia virus Tupaias 
Epsilontorquevirus Torque teno tamarin virus Tamarin 
Etatorquevirus Torque teno felis virus Cat 
Gammatorquevirus Torque teno midi virus Human, chimpanzee 
Gyrovirus Chicken anemia virus Chicken 
Iotatorquevirus Torque teno sus virus 1 Swine 
Kappatorquevirus Torque teno sus virus k2 Swine 
Lambdatorquevirus Torque teno zalophus virus 1 Sea lion 
Thetatorquevirus Torque teno canis virus Dog 
Zetatorquevirus Torque teno douroucouli virus Douroucouli 
 
At present, no definite answers on the replicative sites of TTV have yet been defined, nor does a firm 
evidence exists on the involvement of this virus in disease pathogenesis. While T lymphocyte has 
been listed as a potential replicative site for TTV (Focosi et al., 2015), there was no evidence on the 
specific receptor that could interact with specific proteins present on TTV to allow the viral entry.  
Besides, TTV has been suspected to be a causative agent of hepatitis with early studies supporting the 
involvement of TTV with hepatitis as well as with liver disease (Charlton et al., 1998; Naoumov et al., 
1998). However, given the presence of TTV DNA in non-hepatitis patients including patients with 
respiratory diseases, cancer, haematological and autoimmune diseases as reviewed by Spandole et al. 
(2015), as well as with no significant association recently reported between TTV and hepatitis 
(Hussain et al., 2012; AbuOdeh et al., 2015), the pathogenic potential of TTV as causative agent of 
hepatitis and liver disease seems to be very weak. Apart from diseased patients, healthy individuals 
have been reported to be infected with TTV (Vasilyev et al., 2009; Mazzola et al., 2015) and until 
now, infection with TTV does not result in any sign and symptom, suggesting the non-pathogenic 
property of TTV to human populations.  
 
Although TTV is currently considered to be non-pathogenic, it is possible that, probably due to 
mutation, certain TTV genotypes or species are either a key player of a particular disease or may act 
as co-factor in the progression of any disease. Knowledge on the trend and global widespread of TTV 
infection as well as TTV genetic diversity have a profound impact on the production of vaccine and 
antiviral drug, and the development of drug resistance in the future. Therefore, this review attempts to 
gather the epidemiological data on TTV prevalence among both healthy individuals and diseased 
patients, while at the same time discusses the molecular diagnostics used in TTV detection as well as 
the possible mode of TTV transmission contributing to the high TTV prevalence in the certain studied 
populations. 
 
Genomic Characterization of TTV 
The genome of TTV is made up of circular, negative sense, single-stranded DNA (Miyata et al., 1999; 
Mushahwar et al., 1999), with total length varies among TTV genotypes, which are between 3.8kb to 
3.9kb. Figure 1 displays the schematic illustration of the genomic organisation of TTV, which is 
conserved among various TTV isolates. There are two main regions of TTV genome namely the 
protein-coding region (~2.6kb) and the untranslated region (UTR) (~1.2kb). The occurrence of TTV 
sequence divergence is not evenly distributed throughout the genome; however, UTR is highly 
conserved compared to the protein-coding region. The protein-coding region consists of several open 
reading frames (ORFs), N22-ORF 1 region, hypervariable region (HVR) and N-terminal arginine-rich 
motif (Okamoto et al., 1998a; Muljono et al., 2001; Hussain et al., 2012; Hsiao et al., 2016). TTV has 
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been shown to produce up to four messenger RNAs (mRNA) and the expression of protein results in 
two main ORFs, which are ORF 1 and ORF 2 with several shorter ORFs. The splice site connects the 
distant ORFs and creates new ORFs, such as ORF 3 and ORF 4 (Muljono et al., 2001; Qiu et al., 2005; 
Kakkola et al., 2008; Mueller et al., 2008). It is noteworthy that ORF 1 constitute the longest coding 
sequence and due to a premature stop codon, its expression resulted in a shorter ORF 1 as occurred in 
a few TTV isolates (Jelcic et al., 2004; Hussain et al., 2012). These proteins coding-gene highly 
diverge at nucleotides and amino acids level between isolates, and they encode a different length of 
protein in different isolates (Spandole et al., 2015). The highly conserved region of UTR, which 
stretches from polyadenylation signal to the initiation codon of ORF 2, comprises GC-rich tract and 
several elements important for transcriptional regulation (Okamoto et al., 1998a; Okamoto et al., 
1998b; Mushahwar et al., 1999; Muljono et al., 2001; Kamada et al., 2004; Hussain et al., 2012; Hsiao 
et al., 2016).  
 
 
Figure 1: The schematic illustration of the genomic organisation of TTV. (Source: Okamoto et al., 
1998a; Miyata et al., 1999; Muljono et al., 2001; Kamada et al., 2004; Hussain et al. 2012; Hsiao et al., 
2016)  
 
According to International Committee on Taxonomy of Viruses, ICTV (2015), there are 29 reported 
TTV species and more than 6000 sequences currently available in the National Center for 
Biotechnology Information (NCBI) database that belong to TTV. The cut-off value of the nucleotide 
sequence identity is 50% among TTV species, 30% between the TTV genotypes, 15% to 29% among 
TTV subtypes (Manzin et al., 2015). Phylogenetic analysis of the TTV genome demonstrated that, the 
TTV species and genotypes were classified into five different phylogenetic groups (Hussain et al., 
2012; Mi et al., 2014), however, an additional two groups were recently reported clustering the TTV 
variants into seven groups (Hsiao et al., 2016). Since TTV is made up of a small, single-stranded 
DNA genome, it is likely that the generation of a large number of TTV variant is driven by the high 
mutation rate, which is closer to RNA virus (Sanjuán & Domingo, 2016).  
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Laboratory diagnosis of TTV infection 
To date, none of the laboratory method used for disclosure of TTV epidemiology has the ability to 
detect the entire spectrum of TTV genotypes. The growing number of TTV variants demands a 
development of more sensitive and effective methods in providing the accurate estimation of TTV 
infection. Here, several laboratory methods used in the previous studies were addressed. 
 
PCR is the most prominent method used in TTV detection, which includes standard PCR, nested or 
semi-nested PCR and real-time PCR. Although PCR is a fast and inexpensive technique, in the case of 
TTV, the selection of TTV genomic region targeted for amplification is the most crucial part due to its 
sequence heterogeneity among TTV variants. Detection of the entire spectrum of TTV genotype is 
impossible using only a single set of primer.  
 
Due to historical reason, N22-ORF 1 region has been targeted for amplification (N22 PCR) in a 
number of studies (Muljono et al., 2001; Irshad et al., 2008; El-taher et al., 2015). The use of 
degenerate primers and/or the increase of annealing or extension times can increase TTV detection 
rate of N22 PCR (Biagini et al., 2000). Improvement on the PCR protocol has been done by 
considering the highly conserved region of TTV genome. As evidenced by the previous studies, the 
amplification of 5’ or 3’ UTR (UTR PCR) increased TTV detection rate as compared to amplification 
of N22-ORF 1 region (Koohi et al., 2012; Peng et al., 2015), which will be further discussed in the 
following section. 
 
For the purpose of genotyping, one of the most widely utilised methods is the phylogenetic analysis 
based on either the sequence spanning ORF 1 region or the sequence spanning 5’ or 3’ UTR. 
Determination of TTV genotypes based on the partial sequence of N22-ORF 1 region might not 
represent the real distribution since amplification of the N22 region mainly detects group 1 TTV 
genotype (Peng et al., 2002). Apart from that, PCR using group-specific primers corresponding to the 
five TTV genogroups as well as the restriction fragment length polymorphism (RFLP) in determining 
TTV genogroups were developed. These group-specific primers were designed based on one TTV 
isolate representative of each TTV genogroup. The group-specific primer has been used either in 
standard PCR or multiplex PCR protocol to determine the most widely distributed genogroup 
(Devalle & Niel, 2004; Devalle & Niel, 2005; Wei et al., 2015). In contrast to phylogenetic analysis, 
group-specific primer and RFLP have the ability to demonstrate the occurrence of co-infection with 
multiple TTV genotype within the studied population.  
  
While PCR has the ability to detect the presence of TTV DNA, the method used for diagnosis of TTV 
infection based on detection of TTV antibodies such as immunoblotting, immunoprecipitation, 
immunocapture and Enzyme immunoassay (EIA) has been also developed. The N-terminal and C-
terminal of ORF 1, and ORF 2 protein have been employed as an antigen against circulating TTV 
antibody, and in contrast to PCR, antibody-based detection is able to detect the resolved TTV 
infection (Tsuda et al., 1999; Handa et al., 2000; Ott et al., 2000; Tsuda et al., 2001; Kakkola et al., 
2008).  
 
The prevalence of TTV 
TTV is ubiquitous in the human population; however, its prevalence is varied across different regions 
of the world. The estimated TTV prevalence was mostly based on the detection of TTV DNA. In this 
section, the discussion focuses on TTV prevalence and its genotype distribution by PCR using UTR-
specific and ORF-specific primer for six different continents. In this discussion, amplification of the 
nucleotide sequence spanning UTR is referred to as UTR PCR, whereas the amplification of 
nucleotide sequence spanning ORF 1 is referred to as ORF PCR. 
 
Africa  
The data on TTV infection rate among African populations is very limited. Based on the data 
provided by Smuts et al. (2003) and Hafez et al. (2007), 17% to 84% of African populations are 
infected with TTV regardless of individual’s health status and detection method employed (Table 2). 
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The high prevalence of TTV among rural populations in South Africa as reported by Smuts et al. 
(2003) can be linked with the sanitation level as those who live under poor sanitary conditions may 
have a greater chance to be infected by this virus (Pujol et al., 2005). 
 
Table 2: The prevalence and genotype distribution of TTV in Africa 
 
 
Asia 
Asian continent presents the largest data on TTV prevalence compared to the other continents. 
Meanwhile, the estimated TTV prevalence among Asian population is ranging from 6.67% to 100% 
(Table 3). A few studies have been conducted in Pakistan, Taiwan and Thailand, and based on the 
data reported by Hussain et al. (2012) and Hsiao et al. (2016), TTV infection rate in Pakistan and 
Taiwan was seen to be high, while, Urwijitaroon et al. (2007) reported a low TTV infection rate 
among Thais. While TTV epidemiological study was reported to be limited in a few countries, 
multiple epidemiological studies have been conducted in Iran with up to 92% of the Iranian infected 
by TTV as reported by Koohi et al. (2012). Variability in TTV prevalence among Iranian was noted 
and might be due to the different regions of the TTV genome targeted for amplification as UTR-
specific primer may result in higher detection rate compared to ORF-specific primer. Interestingly, 
three studies conducted by Koohi et al. (2012), Mousavi-Nasab et al. (2013) and Izadi et al. (2016) 
showed a decreasing number of TTV infection rate although they detected the presence of TTV DNA 
using similar set of primer targeted at 5’ UTR (Okamoto et al. 1999). The difference in TTV detection 
rate could be due to several reasons including the growing number of TTV variants over time, the 
medications used that affect TTV replication and low TTV titre of the test samples that may give 
negative results (Chris D et al., 2002; Izadi et al., 2016). In China, Peng et al. (2015) reported that half 
of the infants enrolled in the study were tested TTV positive while the adults showed a high 
percentage of TTV infection rate ranging from 97.5 to 100% as detected using UTR PCR. 
Nevertheless, the detection rate of TTV tended to be lower using ORF PCR (Peng et al., 2015). TTV 
prevalence reported by Wei et al. (2015) was much lower compared to the reported prevalence by 
Peng et al. (2015) possibly due to the group-specific primer used by Wei et al. (2015). The group-
specific primer was design based on the nucleotide sequence of one TTV genotype representative 
from each TTV genogroup (group 1 to 5) and due to the high sequence heterogeneity between TTV 
genotype, certain TTV genotypes could not be detected leading to negative results. 
 
Table 3: The prevalence and genotype distribution of TTV in Asia 
Countries References Subjects Prevalence of TTV (%) Major group / 
genotypes 
detected 
UTR PCR  ORF PCR 
Qoluobia Hafez et al. 
(2007) 
Healthy individuals - 36.7 Genotype 1, 5 
Hepatocellular 
carcinoma 
- 46.7 
Liver cirrhosis - 40 
South Africa Smuts et al. 
(2003) 
Rural community  84 17 Genotype 1, 2 
Countries References Subjects Prevalence of TTV (%) Group / 
Genotypes UTR PCR  ORF PCR  
China Wei et al. (2015)  Cardiovascular 
disease 
14 All group 
detected using 
group-specific 
primer 
Tumour 18.8 
Gastroenteritis 26.7 
Peng et al. (2015)  Adults 98 37.8 - 
Chronic hepatitis B 100 35 
Chronic hepatitis C 97.5 42.5 
Infants 54.7 17.4 
PJSRR (2018) 4(1): 10-24 
eISSN: 2462-2028 © Universiti Putra Malaysia Press 
 
15 
 
 
 
Middle East 
Based on the data gathered from three different countries located in the Middle East (Table 4), the 
high prevalence of TTV was reported among healthy individuals (81.4%) and hepatitis patients (84.9% 
to 90.75%) in Qatar (AbuOdeh et al., 2015), with no significant association between TTV infection 
and hepatitis. In Turkey, the high prevalence of TTV detected using UTR PCR was reported by 
Yazici et al. (2002) (82.7% to 86.4%); however, it is not comparable with the prevalence reported by 
Kalken et al. (2005) (16.8% to 53.1%). In addition, much difference in TTV prevalence detected 
using ORF PCR was observed between the study conducted by Erensoy et al. (2002) (51.6 to 80.0%) 
and Kalken et al. (2005) (12.0 to 31.9%). As stated above, the unspecificity of the primer used, 
different level of TTV titre of the tested samples as well as different background of the studied 
population might have an impact on the estimation of TTV infection. However, there is another issue 
that demands further investigation, which is the contribution of host’s gene polymorphism against 
TTV infection. At present, there are only a few publications exist on the association of TTV infection 
with the host’s gene polymorphism. TTV has been linked with APOBEC3B gene polymorphism, in 
Iran Doosti et al. (2011) Healthy individuals   2.9  
Hepatitis B  8.9  
Hepatitis C  10.8  
Koohi et al. (2012) Chronic Hepatitis C 
patients 
92.0 5.0 Genotype 1, 3, 
11, 17, 22 
Mousavi-Nasab et 
al. (2013) 
Healthy individuals 18.0   
Hepatitis B 50.8   
Hepatitis C 66.5   
Izadi et al. (2016)  Chronic Hepatitis B 
patients 
6.67 - - 
Chronic Hepatitis C 
patients 
13.3 - 
Healthy individuals 10.0 - 
Taheri et al. (2017) Healthy individuals  11.0  
HIV infected  18.8  
India Irshad et al. (2008) Healthy individuals - 26.7 Genotype 1, 2 
Liver disease - 27 
Chronic renal 
failure 
- 58.5 
Magu et al. (2015)  Healthy individuals 72 - 
Hepatitis A 77.4 
Hepatitis B 85.7 
Hepatitis C 77 
Non A-C hepatitis  
92.8 
Indonesia Muljono et al. 
(2001)  
Healthy individuals 95 41.8 Genotype 1, 2, 
3, 22, 23 
Pakistan Hussain et al. 
(2012) 
Healthy individuals 92.5 - Group 2 
Hepatitis B 89.7 - 
Hepatitis C 90 - 
Thailand Urwijitaroon et al. 
(2007)  
Negative HBV and 
HCV 
- 28 - 
Hepatitis B - 25 
Hepatitis C - 29 
Taiwan Hsiao et al. (2016) Healthy individuals 95 - Group 3, 
Group 6 and 7 
(identified in 
this study) 
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which those subjects who were having intact allele, either heterozygous intact / deletion (I/D) or 
homozygous intact (I/I) was associated with high chance of developing TTV viremia compared to 
those who were having homozygous deletion (D/D) (Prasetyo et al., 2017). Besides that, recent study 
by Ramzi et al. (2017) which was conducted among hematopoietic stem cell transplantation patients 
demonstrated the association between cytotoxic T-lymphocyte antigen 4 (CTLA-4) gene 
polymorphism with TTV infection. Among the four types of gene polymorphism, which include -
17722 T/C, -1661 A/G, -318 C/T, and +49 A/G, the prevalence of active TTV infection after the 
transplantation was significantly related to CTLA-4 +49 A/G polymorphism, and among patients with 
low-grade acute GVHD, TTV infection could be linked with CTLA-4 -1661 A/G and CTLA-4 -318 
C/T. The study conducted in Saudi Arabia demonstrated that TTV was prevalent among the 
haemodialysis patients (42.9%) compared to 19% of the control group (P<0.001) (El-taher et al., 
2015).  
 
Table 4: The prevalence and genotype distribution of TTV in Middle East 
 
Europe 
Similar to the African continent, a limited number of TTV epidemiological study among European 
was also observed (Table 5). Within this continent, 50.4% to 95% of patients with blood-borne 
Countries References Subjects Prevalence of TTV (%) Group / 
Genotypes UTR PCR ORF PCR 
Qatar Abu Odeh et al. (2015) Healthy 
individuals 
81.4 - Group 
1,2,3,5 
Hepatitis B 90.75 - 
Hepatitis C 84.9 - 
Turkey Yazici et al. (2002) Prostitute and 
homosexual 
men 
86.4 - - 
Healthy 
individuals 
82.7 - - 
Erensoy et al. (2002) Healthy 
individuals 
- 51.6 Genotype 
1, 2 
Thalassemia - 61 
Fulminant 
hepatitis 
- 80 
Haemodialysis 
patients 
- 75 
Kalkan et al. (2005) Healthy 
individuals 
16.8 12 Genotype 
1,2,3,4 
Mentally 
retarded 
children 
30.6 22.7 
Schizophrenic 
children 
26.7 14.2 
Leprosy cases 32.5 23.2 
Chronic 
hepatitis B 
31.3 19.6 
Chronic 
hepatitis C 
53.1 31.9 
Saudi Arabia El-taher et al. (2015) Haemodialysis 
patients 
- 42.9 Genotype 
1,2,3,4,5,6 
(genotype 1 
most 
common in 
both groups) 
Healthy 
individuals 
- 19 
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diseases, 91.8% of intravenous drug users and 62% of sex workers have been infected with TTV 
(Takács et al., 2003; Saláková et al., 2004), whereas the prevalence of TTV isolated from cancer 
patients was slightly lower, which was 24% to 50% (Hettmann et al., 2016). The high TTV 
prevalence (94%) was also reported among Russian population, which was much higher compared to 
healthy individuals of the Czech Republic (52.6%) (Saláková et al., 2004; Vasilyev et al., 2009).  
 
Table 5: The prevalence and genotype distribution of TTV in Europe 
 
 
North and South America 
According to Table 6, epidemiological study conducted in Canada illustrated that 38.8% of the 
diarrheic individuals were positive for TTV in their stool samples as demonstrated by real-time PCR, 
and significantly high TTV load in stools of diarrhoeic individuals compared to non-diarrhoeic 
individuals (Brassard et al., 2015), thus supporting the hypothesis on the faecal-oral route of TTV 
transmission that will be further discussed in the following section. Meanwhile, in countries within 
South America, such as Brazil and Uruguay, the prevalence of TTV varied from 54% and 100% 
among hepatitis and HIV-1 patients and varied from 46% to 69% among healthy individuals 
regardless of the PCR protocol employed (Devalle & Niel, 2004; Mazzola et al., 2015; Cancela et al., 
2016). 
 
Countries References Subjects Prevalence of TTV (%) Group / 
Genotypes UTR PCR ORF PCR 
Czech 
Republic 
Saláková et al. (2004) Healthy 
individuals 
52.6 - Genotype 
1a, 1b, 2b, 
2c, 8 Haemophilia 
patients 
95 - 
Intravenous 
drug users 
91.8 - 
Sex workers 62 - 
Penitentiary 
prisoners 
74 - 
Healthy children 
(age 1-14) 
67.8 - 
Cord blood 
samples 
0 - 
Non A-E 
hepatitis 
75 - 
Hepatitis C 89.2 - 
Blood donors 
with elevated 
ALT 
60.8 - 
Russia Vasilyev et al. (2009) Healthy 
individuals 
94  
Hungary Hettmann et al. (2016) Head and neck 
carcinoma 
- 30 - 38 Genotype 
1,2,3 
Oral carcinoma - 24 - 50 
Healthy 
individuals 
- 5 - 14 
Takács et al. (2003) Healthy 
individuals 
- 18.5 Group 1 
(genotype 
1,2,6); 
Group 2 
(genotype 8, 
17) 
Hepatitis 
patients 
unknown 
etiology 
- 50.4 
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Table 6: The prevalence and genotype distribution of TTV in North and South America 
 
Multiple Route of TTV Transmission  
Widely distributed TTV infection among human populations might be explained by the multiple 
modes of transmission. TTV could be horizontally transmitted among human population via blood 
and excretory products, and vertically transmitted from mother to infants. Apart from human to 
human transmission, the zoonotic transmission should also be considered as this virus is also known 
to infect animals. Here, a brief description on the several possible routes of TTV transmission is 
presented.  
 
Horizontal Transmission 
Since hematopoietic cells have been hypothesised as the replicative sites for TTV, blood and blood 
products could be among the possible routes for TTV transmission (Zhong et al., 2002; Maggi et al., 
2010). In line with Zhong et al. (2002) and Maggi et al. (2010), Focosi et al. (2015) suggested TTV as 
a T-lymphotropic virus evidenced by the reduction of TTV viremia in parallel with the absolute 
lymphocyte count (ALC) after the induction of immunosuppressive drug among the transplant 
recipients. Besides, TTV DNA was significantly detected in individuals exposed to infected blood or 
blood products including those receiving the blood transfusion or intravenous drug user (Saláková et 
al. 2004; El-taher et al., 2015).   
 
According to Bendinelli et al. (2001), the widespread of TTV infection across different regions of the 
world, and among individuals with a number of conditions and variety of circumstances does not 
solely depend on blood-borne transmission. Given the presence of high TTV prevalence among 
healthy individuals and the worldwide distribution of TTV, it supports the hypothesis on the 
involvement of other modes of transmission in spreading the virus. TTV has been proposed to be 
transmitted via respiratory droplet and saliva through the air. The presence of TTV DNA in nasal 
secretion and saliva of infants as well as healthy adults indicate that the respiratory tract may act as a 
reservoir of TTV (Maggi et al., 2003; Naganuma et al., 2008), and this virus could be spread via 
exhalation (Chikasue et al., 2012).  
 
As evidenced by the presence of TTV DNA in faeces of TTV-infected individuals, there is a 
possibility that this virus is shed into intestine and transmitted into the next host via faecal route 
(Okamoto et al., 1998b). This hypothesis is also in agreement with a recent study among diarrheic and 
non-diarrheic individuals reporting a significant association between TTV infection rate and viral load 
with enteritis (Brassard et al., 2015). In providing more evidence on the faecal-oral route of TTV 
transmission, a number of studies have been carried out on the detection and quantification of TTV 
genome in water from different sources. Low sewage treatment may contaminate food, water supplies 
Countries References Subjects Prevalence of TTV (%) Group / 
Genotypes UTR PCR ORF PCR 
Canada Brassard et al. (2015) Diarrheic 38.8 
 
- 
Non-diarrheic 
 
18.4 - 
Brazil Mazzola et al. (2015) Healthy 
individuals 
- 69.0 -  
Devalle and Niel (2004) Healthy 
individuals 
46 All groups 
(1-5) were 
detected 
using 
group-
specific 
primers 
Hepatitis B 54 
 
HIV type 1 
(HIV-1) 
100 
 
Uruguay Cancela et al. (2016) Hepatitis 
patients 
79.0 - Group 3 
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and living area, which contribute to the faecal-oral cycle of TTV (Dalla Vecchia et al., 2013). 
Analysis on the enteric virus presence in water samples in Brazil revealed that detection rate of TTV 
DNA in surface water and in effluent sample of sewage water by means of PCR were 28.57% and 
12.5%, respectively (Vecchia et al., 2012a; Vecchia et al., 2012b). The shedding of TTV particles into 
faeces demonstrated that this non-enveloped virus might be highly resistant to water environment 
(Flint et al., 2015). 
 
Vertical Transmission 
Although scarce, some evidence exist on the vertical transmission of TTV from mother to child, either 
prenatal or postnatal (Davidson et al., 1999; Maggi et al., 2003; Ninomiya et al., 2008). Cord blood 
and amniotic fluid (transplacental transmission) (Gerner et al., 2000; Matsubara et al., 2001) may act 
as a vehicle in transmitting TTV DNA from mother to infant during the prenatal period. While 
Bagaglio et al. (2002) was able to demonstrate the presence of TTV DNA in infants at birth, which 
was in line with the study by Gerner et al. (2000) on TTV nucleotide sequence analysis isolated from 
mother-child pairs infected with TTV that showed the sequence homology, a few other studies 
demonstrated the lack of cord blood as well as amniotic fluid as a medium of TTV transmission (Kazi 
et al., 2000; Iso et al., 2001; Ninomiya et al., 2008; Tyschik et al., 2017). Ninomiya et al. (2008) failed 
to detect presence of TTV DNA within cord blood; however, they reported that the prevalence of 
infants infected with Anellovirus DNA increased with the number of months after birth with the first 
appearance was detected at 20 days of age (Ninomiya et al., 2008), indicating the postnatal acquisition 
of TTV. Several studies provided an evidence on the possibility of the breast milk to act as a medium 
in transmitting the virus during the postnatal period (Gerner et al., 2000; Schröter et al., 2000; Iso et 
al., 2001; Matsubara et al., 2001); however, it deserves further investigation since infants born to 
uninfected mothers who were refrained from breastfeeding their infants were positive for TTV DNA 
(Kazi et al., 2000).  
 
Cross-species Transmission 
The Anelloviridae family is not restricted to the human-infected virus. A number of Anellovirus 
species have been considered as the animal-infected viruses that infect animal such as pigs, dogs, 
macaque, tupaias, and non-human primates (ICTV 2015). Since it infects both human and animal, it 
owes the answer on the potential cross-species transmission of TTV. In an attempt to find the possible 
source of TTV infection among human, several studies conducted on non-human primates revealed 
that TTV variants are species-specific (Leary et al., 1999; Okamoto et al., 2000a; Okamoto et al., 
2000b), with 66 to 90% of the nucleotide sequence of TTV genotype 1a (isolate TA278) similar to 
TTV isolated from chimpanzee, thus suggesting the possible cross-infection of TTV between human 
and chimpanzee (Okamoto et al., 2000). As reported by Iwaki et al. (2003), 10% of the Japanese 
patients who suffered from liver diseases are infected with simian TTV. The hypothesis for the 
possible cross-species infection of TTV is supported by the recent evidence provided by Ssemadaali 
et al. (2016). They reported that, most of the human sera tested were infected with both human TTV 
and swine TTV (TTSuV). Further investigation revealed that human PBMCs have the ability to 
support the TTSuV DNA replication and its respond towards immune stimulation significantly 
declined upon infection with TTSuV DNA (Ssemadaali et al., 2016). These findings may provide the 
fundamental knowledge on the possible interspecies transmissions of TTV. However, further studies 
are warrant to provide more significant evidence especially in the context of disease pathogenesis.  
 
Conclusion 
The study on TTV has started 20 years ago. Nonetheless, many aspects of this virus are still 
controversial. TTV prevalence is a geographically variable and there are certain regions of the world 
that are yet to be studied. Despite the presence of TTV DNA in individuals with a number of health 
conditions, TTV is also prevalent among healthy individuals. At present, the role of TTV in the 
pathogenesis of the disease is still unknown and infection with this virus result in no sign and 
symptom. Prevalence study on TTV may give the estimation on the ubiquity of TTV and widespread 
of its infection, however, a more efficient assay is needed to measure the impact of this virus on 
human health. 
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